Huilan Zeng

920 citations
51 papers · 705 indexed · h-index 16
Topics
Cancer-related molecular mechanisms research (8 papers)Mycorrhizal Fungi and Plant Interactions (5 papers)interferon and immune responses (4 papers)
Partner nations
ChinaAustraliaJapan

In The Last Decade

Huilan Zeng

49 papers receiving 695 citations

Peers

Huilan Zeng
Comparison fields: 5 of 97
  • Molecular Biology 316
  • Cancer Research 139
  • Plant Science 90
  • Biomaterials 82
  • Ophthalmology 69
Replace Jinxia Wang with:
Jinxia Wang China
Pitchumani Sivakumar India
Harry C. Ledebur United States
Gürler Akpınar Türkiye
Jinsong Zhang China
S. J. Rosochacki Poland
Bob Beekman Netherlands
Preethi Vijayaraj United States
Chunli Zhang China
Huilan Zeng relative to Jinxia Wang China Jinxia Wang's profile →
Citations per field
00.5×
Jinxia Wang · 1×
Citations per year

Countries citing papers authored by Huilan Zeng

Since Specialization
Citations

This map shows the geographic impact of Huilan Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilan Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilan Zeng more than expected).

Fields of papers citing papers by Huilan Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huilan Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilan Zeng. The network helps show where Huilan Zeng may publish in the future.

Co-authorship network of co-authors of Huilan Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Huilan Zeng. A scholar is included among the top collaborators of Huilan Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huilan Zeng. Huilan Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 7
5 5
6 12
7 11
8 11
9 3
10 11
11 6
12 34
13
Identification, biological characteristics and sensitivity of the causal pathogen inducing leaf dieback on lily.
1
14 25
15 13
16 8
17 31
18 23
19 44
20 16

About Huilan Zeng

Huilan Zeng is a scholar working on Cancer Research, Hematology and Ophthalmology, having authored 51 papers that have together received 705 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Mycorrhizal Fungi and Plant Interactions (5 papers) and interferon and immune responses (4 papers). The work is most often cited by research in Cancer Research (139 citations), Ophthalmology (69 citations) and Biomaterials (82 citations). Huilan Zeng has collaborated with scholars based in China, Australia and Japan. Frequent co-authors include Jingming Shi, Jianwu Wang, Yinghua Shu, Feng Ge, Yedi Zhou, Qing‐Yu He, Yuechun Wang, Xing Wei, Shigeo Yoshida and Jingling Zou. Their work appears in journals such as PLoS ONE, Chemistry of Materials and Chemosphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026